Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Osama Y. Alshogran, Esraa A. Shatnawi, Shoroq M. Altawalbeh, Anan S. Jarab & Randa I. Farah. (2022) Medication non-adherence and the achievement of therapeutic goals of anemia therapy among hemodialysis patients in Jordan. Hospital Practice 50:1, pages 82-88.
Read now
Read now
Saija Inkeroinen, Jenni Koskinen, Mia Karlsson, Taina Kilpi, Helena Leino-Kilpi, Pauli Puukka, Ros-Marie Taponen, Riitta Tuominen & Heli Virtanen. (2021) Sufficiency of Knowledge Processed in Patient Education in Dialysis Care. Patient Preference and Adherence 15, pages 1165-1175.
Read now
Read now
Michel Vallée, Jordan Weinstein, Marisa Battistella, Roxanne Papineau, Dianne Moseley & Gordon Wong. (2021) Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia. International Journal of Nephrology and Renovascular Disease 14, pages 301-311.
Read now
Read now
Rachel L Snyder, Bernard G Jaar, Janice P Lea & Laura C Plantinga. (2020) Association of Patient-Reported Difficulty with Adherence with Achievement of Clinical Targets Among Hemodialysis Patients. Patient Preference and Adherence 14, pages 249-259.
Read now
Read now
Articles from other publishers (20)
Christopher M. Celano, Juliana Zambrano, Lauren Harnedy, Daniel Arroyo‐Ariza, Alba Carrillo, Wei‐Jean Chung, Christina N. Massey, Abraham Cohen‐Bucay & Jeff C. Huffman. (2022) A novel health behaviour intervention to promote adherence in kidney failure. Journal of Renal Care 49:1, pages 24-34.
Crossref
Crossref
Connie M. Rhee, Meijiao Zhou, Rachael Woznick, Claudy Mullon, Michael S. Anger & Linda H. Ficociello. (2022) A real-world analysis of the influence of age on maintenance hemodialysis patients: managing serum phosphorus with sucroferric oxyhydroxide as part of routine clinical care. International Urology and Nephrology 55:2, pages 377-387.
Crossref
Crossref
Xiaojun Wang, Yanping Xu, Xiaohong Yu, Asim Dey, Hong Y. Zhang, Charity M. Zink, Derek Wodka, Gina Porter, William F. Matter, Leah Porras, Charles A. Reidy, Jeffrey A. Peterson, Brian E. Mattioni, Joseph V. Haas, Mark C. Kowala & John R. Wetterau. (2022) Effects of pharmacological inhibition of the sodium‐dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat models. Pharmacology Research & Perspectives 10:2.
Crossref
Crossref
Tess E. Cooper, Amy Dalton, Anh Kieu, Martin Howell, Sumedh Jayanti, Rabia Khalid, Wai H. Lim, Nicole Scholes-Robertson, Jonathan C. Craig, Armando Teixeira-Pinto, Michael J. Bourke, Allison Tong & Germaine Wong. (2021) The CKD bowel health study: understanding the bowel health and gastrointestinal symptom management in patients with chronic kidney disease: a mixed-methods observational longitudinal study (protocol). BMC Nephrology 22:1.
Crossref
Crossref
Geoffrey A. Block, Anthony J. Bleyer, Arnold L. Silva, Daniel E. Weiner, Robert I. Lynn, Yang Yang, David P. Rosenbaum & Glenn M. Chertow. (2021) Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM). Kidney360 2:10, pages 1600-1610.
Crossref
Crossref
Pablo E. Pergola, David P. Rosenbaum, Yang Yang & Glenn M. Chertow. (2021) A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY). Journal of the American Society of Nephrology 32:6, pages 1465-1473.
Crossref
Crossref
Jerry Yee, David Rosenbaum, Jeffrey W. Jacobs & Stuart M. Sprague. (2021) Small Intestinal Phosphate Absorption: Novel Therapeutic Implications. American Journal of Nephrology 52:7, pages 522-530.
Crossref
Crossref
Helena Sousa, Oscar Ribeiro, Elísio Costa, Roberta Frontini, Constança Paúl, Leonilde Amado, Vasco Miranda, Fernando Ribeiro & Daniela Figueiredo. (2020) Being on hemodialysis during the COVID‐19 outbreak: A mixed‐methods’ study exploring the impacts on dialysis adequacy, analytical data, and patients’ experiences. Seminars in Dialysis 34:1, pages 66-76.
Crossref
Crossref
Ebele M Umeukeje, Rabia Osman, Arie L Nettles, Kenneth A Wallston & Kerri L Cavanaugh. (2019) Provider Attitudes and Support of Patients’ Autonomy for Phosphate Binder Medication Adherence in ESRD. Journal of Patient Experience 7:5, pages 708-712.
Crossref
Crossref
Eileen Suk Ying Ng, Poh Yoong Wong, Ahmad Teguh Hakiki Kamaruddin, Christopher Thiam Seong Lim & Yoke Mun Chan. (2020) Poor Sleep Quality, Depression and Social Support Are Determinants of Serum Phosphate Level among Hemodialysis Patients in Malaysia. International Journal of Environmental Research and Public Health 17:14, pages 5144.
Crossref
Crossref
Anastasia Markaki, Emmanuel Psylinakis, Xenophon Theodoridis, Petros Dimitropoulakis, Aikaterini Charonitaki & Aspasia Spyridaki. (2020) Association between dietary intake and nutritional status in Eastern Mediterranean patients receiving hemodialysis. Mediterranean Journal of Nutrition and Metabolism 13:2, pages 175-182.
Crossref
Crossref
Mario Cozzolino, Eugeniy Shilov, Zuo Li, Masafumi Fukagawa, Saeed M. G. Al-Ghamdi, Ronald Pisoni, Brian Bieber, Bhadrish Vallabh & Deepa H. Chand. (2020) Pattern of Laboratory Parameters and Management of Secondary Hyperparathyroidism in Countries of Europe, Asia, the Middle East, and North America. Advances in Therapy 37:6, pages 2748-2762.
Crossref
Crossref
Donald A. Molony, Vidhya Parameswaran, Linda H. Ficociello, Claudy Mullon & Robert J. Kossmann. (2020) Sucroferric Oxyhydroxide as Part of Combination Phosphate Binder Therapy among Hemodialysis Patients. Kidney360 1:4, pages 263-272.
Crossref
Crossref
Adrian R. Levy, Shan Xing, Steven M. Brunelli, Kerry Cooper, Fredric O. Finkelstein, Michael J. Germain, Miriam Kimel, Robert W. Platt & Vasily Belozeroff. (2020) Symptoms of Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis: A Prospective Cohort Study. American Journal of Kidney Diseases 75:3, pages 373-383.
Crossref
Crossref
Ebele M. Umeukeje & Kerri L. Cavanaugh. (2020) Intradialytic Symptoms and Recovery Time: Thinking ‘Outside the Box’ to Improve Patients’ Dialysis Experience. Kidney Medicine 2:2, pages 98-101.
Crossref
Crossref
Ruth Kander. (2020) Renal bone disease: a dietitian's perspective. Journal of Kidney Care 5:1, pages 18-25.
Crossref
Crossref
Adrian C. Covic, Stuart M. Sprague, Anjay Rastogi, Markus Ketteler, Sebastian Walpen, Amandine Perrin & Jürgen Floege. (2020) Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study. Nephron 144:9, pages 428-439.
Crossref
Crossref
William A. Wolfe. 2020. Nutrition in Kidney Disease. Nutrition in Kidney Disease
123
146
.
Xingjuan Tao, Haifen Zhang, Yan Yang, Caihong Zhang & Min Wang. (2019) Daily dietary phosphorus intake variability and hemodialysis patient adherence to phosphate binder therapy. Hemodialysis International 23:4, pages 458-465.
Crossref
Crossref
Olufunmilola Adisa, Bernard G. Jaar, Tahsin Masud, Abyalew Sahlie, Catherine Obadina, Joshua Ang, Janice P. Lea & Laura C. Plantinga. (2018) Association of social worker-assessed psychosocial factors with 30-day hospital readmissions among hemodialysis patients. BMC Nephrology 19:1.
Crossref
Crossref